Recent Articles from Investor Brand Network

Solana and the rest of the crypto market has gone through many ups and downs over the last few years. The current volatility and pressures in the market, encouraged by ongoing geopolitical factors, have led to attractive entry prices for those looking to get involved with crypto. Current prices, along with growing concern about the future of the USD and other fiat currencies, provide a unique buy-low opportunity for investors who either missed out on getting in on crypto before, or are looking to increase their investment in the space.

Applied Digital (NASDAQ: APLD) announced that its subsidiary, APLD ComputeCo 2 LLC, priced a $2.15 billion offering of 6.750% senior secured notes due 2031 at an issue price of 98%, with the transaction closing March 10, 2026. The notes were sold in a private offering to qualified institutional buyers under Rule 144A and to non-U.S. investors under Regulation S, with Roth Capital Partners acting as co-manager.

Massimo Group (NASDAQ: MAMO), operating through its Massimo Motor division, today announced continued expansion of its electric vehicle fleet across municipal, commercial and institutional markets, alongside development of its second-generation autonomous patrol golf cart platform. The company is deploying vehicles across site-based environments including public safety, property management, campuses and industrial facilities, reflecting rising demand for durable, cost-efficient solutions for recurring use. In parallel, Massimo is advancing a next-generation platform designed with integrated autonomous patrol capabilities, continuous monitoring and real-time communication functionality, enabling extended operations and direct data transmission to personnel, with potential applications across manufacturing, commercial properties, campuses, parks and logistics sites.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

American Fusion (OTC: AMFN) is featured in AINewsWire editorial coverage examining how surging artificial intelligence adoption is driving unprecedented demand for electricity and reshaping global energy infrastructure priorities. The report underscores that hyperscale data centers and AI workloads are rapidly increasing power consumption, creating bottlenecks in aging grid systems and elevating energy availability as a critical constraint on future AI growth.

Oncotelic Therapeutics (OTCQB: OTLC) was highlighted in a BioMedWire editorial examining how advancing drug pipelines are increasingly being recognized as measurable financial assets under U.S. GAAP, reflecting a broader shift in biotech valuation. The company was noted for leveraging its diversified pipeline and strategic holdings, including a 45% stake in GMP Bio, recently valued at more than $1 billion, as an example of how scientific progress and proximity to commercialization can directly enhance balance sheet value and investor perception.

NanoViricides, Inc. (NYSE American: NNVC) announced that its antiviral drug candidate NV-387 may address the growing global measles outbreak, citing recent case surges including more than 18,000 suspected infections in Bangladesh and rising cases in the United States. The company stated that NV-387 has demonstrated safety in Phase I clinical trials and efficacy in animal models, positioning it as a potential therapeutic complement to vaccination by reducing transmission and treating infected patients, particularly among vulnerable populations, while also noting plans to pursue orphan and rare pediatric disease designations with the FDA.

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

The closure of the Strait of Hormuz, alongside China’s decision to halt exports of sulfuric acid from May 1, is tightening global supplies of a critical chemical used in copper production. The combined effect is placing mounting pressure on both the agricultural and mining industries, which depend heavily on acid-intensive processes.

China has committed to doubling its clean energy supply within the next decade, with a substantial expansion milestone set for 2030. A senior official at the National Development and Reform Commission delivered the announcement on April 17. The statement added long-awaited specificity to a target embedded in the country’s latest five-year plan, which had left the precise definition of what was to be doubled unresolved.

Electric vehicles have broken free of the oil price cycle that governed their previous adoption waves. While earlier sales surges typically collapsed when energy prices fell and the underlying economic case evaporated, the current expansion rests on an entirely different foundation. The self-reinforcing economics of battery manufacturing have completely changed the economics of owning a battery electric vehicle (BEV).

Primary and metastatic central nervous system (CNS) tumors can have extraordinary biological and anatomical complexity, and these tumors can be hard to identify using traditional imaging or histopathology analysis. Molecular analysis has emerged as a major way to identify these tumors and help medical teams plan how best to help those diagnosed with these cancers.

The White House has described a recent meeting with the leader of AI company Anthropic as “constructive and productive,” signaling a possible shift in tone between the federal government and a firm currently locked in a legal dispute with the Defense Department.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

AINewsWire Editorial Coverage : Artificial intelligence (“AI”) is no longer just a software revolution; it is rapidly becoming an energy story. As AI models grow larger and more complex, the computational power required to train and operate them is driving a surge in electricity demand that is beginning to outpace existing infrastructure. Hyperscale data centers, once viewed as digital backbones, are now emerging as some of the most energy-intensive assets in the global economy. This shift is forcing governments, utilities and private industry to confront a new reality: energy infrastructure, not computing capability, may become the defining constraint of the AI era. Amid this transition, American Fusion(TM) Inc. (OTC: AMFN) ( Profile ) is positioning itself at the intersection of advanced energy and next-generation infrastructure. Through its focus on aneutronic fusion and related supply chain development, the company is working toward scalable, high-efficiency energy systems designed to meet the demands of AI-driven workloads. Its approach reflects a broader shift across the energy sector, from theoretical innovation toward deployable solutions capable of supporting long-term infrastructure needs. American Fusion joins other leading companies operating at the convergence of AI, electricity demand and energy infrastructure, including NVIDIA Corporation (NASDAQ: NVDA), Microsoft Corporation (NASDAQ: MSFT), Amazon.com Inc. (NASDAQ: AMZN) and…

Wearable Devices (NASDAQ: WLDS) a technology growth company specializing in AI-powered touchless sensing wearables, announced a warrant inducement agreement with an existing institutional investor for the immediate exercise of warrants to purchase up to 2,904,499 ordinary shares at $1.73 per share, generating approximately $5.0 million in gross proceeds. The company plans to use the net proceeds for working capital and general corporate purposes. As part of the agreement, the investor will receive new unregistered warrants to purchase up to 5,082,873 shares at an exercise price of $1.51 per share, exercisable immediately and expiring in five years, with closing expected on or about April 21, 2026, subject to customary conditions.

Backers of a proposed medical marijuana measure in Idaho say they have surpassed 100,000 collected signatures and are now racing to meet an April 30 deadline that would place the issue before voters in November.

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising.

Massimo Group (NASDAQ: MAMO) announced the appointment of Quenton Petersen as Chief Executive Officer, effective April 14, 2026, with David Shan transitioning to Executive Chairman while remaining actively involved in the Company’s strategic direction. Petersen, a nine-year veteran of the company, emphasized continued growth across utility vehicles and electric mobility, alongside a disciplined evaluation of opportunities to integrate advanced technologies such as AI-enabled features and expand into applications including facility operations and smart mobility.

Genius Group (NYSE: GNS) announced the closing of its previously disclosed registered direct offering, raising gross proceeds of approximately $8.0 million through the sale of 21,621,621 ordinary shares (or pre-funded warrants in lieu thereof). The offering was conducted under the Company’s effective shelf registration statement, with D. Boral Capital LLC serving as exclusive placement agent, and proceeds are expected to support the Company’s continued growth as an AI-powered education platform.

By Christopher J. Schaber, chairman, president, and CEO, Soligenix; published via Clinical Leader

Channelchek, a Noble Financial Group platform, highlights a changing investment landscape in 2025, where capital is increasingly rotating toward differentiated growth opportunities beyond crowded sectors. Within this environment, Enhanced Group Inc.—an emerging sports, media, and consumer health company— is pursuing a public market debut through a proposed business combination with A Paradise Acquisition Corp. (NASDAQ: APAD) , positioning itself within a more selective and disciplined SPAC market.

Wearable Devices (NASDAQ: WLDS) announced a planned cooperation and partnership with Meta-Bounds Inc. to integrate its Mudra neural wristband technology with augmented reality hardware, aiming to enable seamless, touchless spatial interaction. The companies intend to showcase early results of the collaboration at Augmented World Expo 2026 in Long Beach, California, with an initial focus on developing wristband-based controls for AR glasses and a longer-term strategy centered on enterprise partnerships and scalable B2B integration.

Oragenics (NYSE American: OGEN) announced that two patients have been enrolled and eight doses administered in its ongoing Phase IIa clinical trial evaluating ONP-002, its lead candidate for the treatment of mild traumatic brain injury (mTBI), or concussion. The trial is underway at Mackay Base Hospital in Queensland, Australia, with additional sites nearing activation, as the company advances a first-in-class intranasal neurosteroid designed to target the underlying biological effects of brain injury, addressing a significant unmet need in a market with no FDA-approved pharmacological treatments.

OptimumBank Holdings (NYSE American: OPHC) announced that Brean Capital, LLC has initiated equity research coverage of the company, with Director of Research Christopher Marinac assigning a Buy rating and an $8 price target. The report, distributed to Brean’s institutional client base, underscores growing recognition of the company’s business model, operating performance and long-term growth strategy, according to Chairman Moishe Gubin, who highlighted the initiation as a key step in expanding investor awareness.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to homeownership, is advancing its strategy to embed mortgage and title services directly into digital real estate platforms, with a newly announced partnership with Structured Real Estate Group (“SRG”). The agreement, detailed in a company press release, positions Beeline’s technology inside SRG’s AI-driven property ecosystem, allowing users to move from property selection to financing without leaving a single interface ( https://ibn.fm/DEI7p ).

Oncotelic Therapeutics (OTCQB: OTLC) is featured in recent BioMedWire editorial coverage highlighting a fundamental shift in biotechnology, where scientific progress is increasingly recognized as measurable financial value rather than purely as research expenditure. As clinical-stage assets advance toward commercialization, fair-value accounting frameworks under U.S. GAAP are enabling companies to reflect pipeline progress, probability of success and timing of market entry directly on the balance sheet. Within this evolving landscape, Oncotelic exemplifies the trend through its diversified oncology pipeline and strategic holdings, including its 45% stake in GMP Bio, recently measured at an enterprise value exceeding $1 billion, demonstrating how advancing science can materially strengthen financial positioning.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Aditxt (NASDAQ: ADTX) announced its precision oncology subsidiary, Ignite Proteomics, was featured in a peer-reviewed study published in npj Precision Oncology, a Nature journal, evaluating treatment outcomes in metastatic breast cancer patients receiving trastuzumab deruxtecan. The study found that quantitative HER2-related assays, including Ignite’s Reverse Phase Protein Array platform, provided more predictive insight into patient outcomes than traditional immunohistochemistry methods in certain sub-cohorts, highlighting the potential of advanced biomarker approaches to improve treatment selection in oncology.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Lantern Pharma (NASDAQ: LTRN) announced it has scheduled a mid-May 2026 Type C meeting with the U.S. Food and Drug Administration to seek feedback on proposed protocol amendments to its Phase 2 HARMONIC(TM) trial evaluating LP-300 in non-small cell lung cancer. The proposed changes include focusing enrollment on EGFR Exon 21 L858R patients, shifting to a single-arm study design and extending treatment cycles, supported by emerging clinical data showing an 8.3-month median progression-free survival and encouraging response rates in this difficult-to-treat population.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

NRx Pharmaceuticals (NASDAQ: NRXP) welcomed a newly signed Executive Order aimed at accelerating medical treatments for serious mental illness, including expanded access to psychedelic therapies and faster regulatory pathways. The order directs the FDA to issue priority vouchers for qualifying breakthrough therapies and encourages broader use of clinical trial data and real-world evidence, aligning with NRx’s strategy as it advances its NRX-100 drug candidate and seeks regulatory support to address severe depression, PTSD and suicidality.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Most digital communications are secured by encryption built on mathematical problems so hard that conventional computers cannot realistically solve them. That assumption could soon be broken by quantum computers that exploit properties of matter at subatomic scales to perform certain calculations far more efficiently than conventional machines ever could.

Snapchat’s parent company, Snap Inc., has announced a major round of layoffs, cutting about 1,000 jobs, which is around 16 percent of its workforce. The company is also removing hundreds of open job listings as it shifts its focus toward a leaner and more efficient way of operating. This decision reflects a growing trend in the tech industry where companies are turning to artificial intelligence to handle routine tasks that were once done by humans.

Gold ended the week trading within a limited range as traders and investors remained uncertain about the near-term outlook of prices. Investors remain cautious as there is uncertainty about how talks between the United States and Iran will play out while the clock is ticking down on the 14-day ceasefire that paved the way for these talks.

This article has been disseminated on behalf of Planet Ventures Inc. and may include paid advertising.

This article has been disseminated on behalf of ESGold Corp. and may include paid advertising.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

AINewsWire Editorial Coverage : For decades, GPS has operated as the invisible infrastructure underpinning modern warfare, enabling everything from precision-guided munitions to autonomous drone navigation. That assumption of reliability is now disappearing in real time. Across active conflict zones, satellite navigation signals are being jammed, spoofed and degraded at scale, turning one of the most trusted systems in defense into one of its most vulnerable. The consequences are immediate and measurable: Drones lose positioning, missions fail mid-operation and entire systems become ineffective in contested environments. As electronic warfare capabilities advance, GPS is increasingly becoming the first system adversaries attempt to disable, forcing a rapid reassessment of how modern platforms operate without it. In response, defense organizations worldwide are accelerating the search for alternatives that can function independently of satellite signals.

Blockchain Futurist Conference announced a six-year exclusive partnership with Krown Technologies, Inc., naming Krown Network the Exclusive Official Quantum Blockchain and Qastle Wallet the Exclusive Official Quantum Wallet across its Toronto and Florida events beginning in 2026. The agreement grants Krown category exclusivity across both flagship markets and includes major branded activations such as The Krown Network Main Stage, a Florida title-level presence and a Toronto VIP cabana experience, positioning Krown’s quantum-secured blockchain ecosystem and Qastle Wallet’s digital asset platform at the center of engagement with founders, investors, developers, enterprises, media and the broader Web3 community.

BioMedWire Editorial Coverage: Biotechnology is undergoing a quiet but profound transformation, one that is reshaping how investors understand value in a sector historically defined by long timelines and uncertain outcomes. As drug candidates advance closer to commercialization, scientific progress is no longer viewed solely as research expenditure but increasingly as a measurable financial asset. This shift is being reinforced by fair-value accounting under U.S. GAAP, which allows life sciences companies to reflect clinical progress, probability of success and commercialization timing as measurable balance sheet value. Leading companies, such as Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ), are keenly aware of this evolution and are leveraging their expertise as pioneers in this space. Through its diversified pipeline and strategic holdings, including a 45% ownership stake in GMP Bio, which was recently measured at more than $1 billion enterprise value, the company exemplifies how advancing science can directly influence financial positioning. As the biotech sector increasingly aligns valuation with progress rather than revenue alone, Oncotelic provides a case study in how innovation is becoming a recognized asset class. Oncotelic joins an elite group of other key companies focused on advanced biotech platforms that target disease at the genetic or molecular level, including Sarepta Therapeutics Inc. (NASDAQ: SRPT), Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY), Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and…

Safe Pro Group (NASDAQ: SPAI) reported continued execution of its share repurchase program, with 400,000 shares repurchased as of April 17, 2026, representing approximately 3.5% of its public float under a $3.0 million authorization approved in December 2025. The company funded repurchases through operating cash flow and its strong balance sheet, which included $16.7 million in cash and no debt at year-end 2025, and said it may continue opportunistic buybacks while investing in its AI-enabled defense and security platform and long-term growth initiatives.

The Nebraska Medical Cannabis Commission has approved a set of rules governing the state’s emerging cannabis supply system, almost a year after first adopting temporary guidelines.

Amid increased demand for advanced collision-avoidance systems as rail networks grow more complex, Rail Vision’s (NASDAQ: RVSN) artificial-intelligence (“AI”)-powered electro-optical sensors are emerging as a direct technological response. “Rail Vision develops vision-based detection systems designed to improve railway safety and operational performance, offering real-time obstacle detection and situational awareness that align closely with evolving safety priorities across the industry,” reads a recent article.

Boca Raton, Florida-based LIXTE Biotechnology Holdings (NASDAQ: LIXT) spent 2025 expanding its presence across multiple segments of oncology innovation. “The company is best known for its clinical-stage pharmaceutical pipeline built around LB-100, a first-in-class inhibitor of protein phosphatase 2A (‘PP2A’),” a recent article reads. “Rather than replacing established cancer therapies, LB-100 is designed to enhance their effectiveness. By inhibiting PP2A, the compound stimulates cell-cycle progression and interferes with DNA repair in cancer cells, potentially making tumors more responsive to chemotherapy and immunotherapy. LB-100 is currently being evaluated in multiple clinical programs targeting solid tumors with significant unmet medical need, including ovarian clear cell carcinoma, metastatic colon cancer and advanced soft tissue sarcoma.”

Artificial intelligence-powered cardiovascular medicine company Cardio Diagnostics Holdings (NASDAQ: CDIO) was featured in a recent article that discussed its focus on cardiovascular disease prevention, detection, and management. The publication reads, “The company’s approach is centered on advancing how cardiovascular disease is addressed by moving beyond traditional methods that rely on indirect or generalized indicators… At the core of its strategy is the integration of epigenetics, genetics, and artificial intelligence to generate insights from a patient’s molecular profile. By analyzing both inherited predisposition and changes influenced by lifestyle and environment, the company’s platform is designed to provide a more complete view of cardiovascular disease.”

Suntex Enterprises (OTC: SNTX) announced the filing of its annual financial statements, highlighting a completed operational restructuring and simplified capital structure with no outstanding debt or convertible instruments. The company also confirmed submission of a corporate action to FINRA seeking approval for a shareholder dividend tied to a diversified portfolio of operating businesses, as Suntex advances a strategy focused on scaling its subsidiaries through organic growth and acquisitions while targeting approximately $100 million in annual revenue and evaluating potential uplisting opportunities.

Recognition from global regulatory authorities can serve as a powerful validation of a therapy’s potential, particularly in the rare disease space where development challenges are significant and patient needs are urgent. Soligenix (NASDAQ: SNGX) has secured that type of validation, as the European Commission granted orphan drug designation to its investigational therapy SGX945 for the treatment of Behçet’s disease, reinforcing both the promise of the therapy and the company’s broader development strategy.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

Cancer treatment is entering a phase where the question is no longer which single therapy works best, but how treatments can be combined to improve outcomes. Across oncology, resistance and relapse remain persistent challenges, and the industry’s response has been increasingly clear: multi-drug regimens targeting different biological pathways are delivering results that single agents cannot.

Despite strong support for fossil fuels under the Trump administration, renewable energy in the United States continued to expand last year, reaching new highs. Clean energy sources generated about 26% of the country’s electricity, which equates to enough power for more than 100 million homes for a year. Renewables also accounted for about 33% of total utility-scale capacity, highlighting their growing importance in the national energy mix.

A new study suggests that generative AI has yet to develop the level of reasoning required for safe use in clinical settings. While recent systems show stronger performance when given detailed patient information, researchers found they still struggle with one of the most critical aspects of medical decision-making.

N issan has unveiled plans to transform vehicular mobility using a combination of electrification, artificial intelligence (AI), and a vehicle lineup focused on the global market. Although the Japanese carmaker did not go all-in on electrification like its Western counterparts, Nissan had a pair of fully electric models by early 2026 and has pledged to launch 19 new EV models by the end of the decade .

A survey that was conducted toward the end of last year by Gallup and West Health found that a sizeable number of Americans are using AI to supplement their interactions with healthcare providers. However, the specifics of how people used these digital tools varied based on age groups, income level and motivations.

Britain’s grid operator is launching a program encouraging households to increase electricity consumption this summer during periods when renewable generation exceeds network capacity. National Energy System Operator plans to alert energy suppliers when surplus wind and solar output overwhelms absorption capability, allowing companies to offer customers free or discounted electricity during those windows.

Bitcoin climbed past the $75,000 mark earlier in the week, reaching its highest level in nearly a month and signaling a shift in market sentiment after weeks of uncertainty. The move marks the first time the crypto has traded at this level since mid-March, following renewed optimism surrounding easing geopolitical tensions in the Middle East.

Lawmakers in Maine have signed off on a bill designed to place a moratorium on the construction of data centers within the state. If signed into law, the legislation would be the first such measure in the entire United States and could set the pace for nearly a dozen other states considering similar proposals.

Southeast Asia’s e-commerce sector continued its strong rise in 2025, reaching a total value of $157 billion, according to a new report by Momentum Works. This growth shows how online shopping is becoming a major part of everyday life across the region, driven by better technology, improved delivery systems, and changing consumer habits.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Gaxos.ai (NASDAQ: GXAI) announced the expansion of its Gaxos Labs ecosystem with the addition of AI music generation, AI chat and AI 3D model creation capabilities, driving increased user engagement across its platform. The new features enhance the company’s suite of generative AI tools spanning image, video and text applications, as Gaxos advances its strategy to deliver scalable, creativity-focused solutions for consumer, creator and commercial markets while capitalizing on growing global demand for AI-driven content generation.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced the closing of its underwritten public offering of 12.5 million shares of common stock, generating gross proceeds of $10 million before expenses, with the transaction completed on April 16, 2026. The offering, supported by key stakeholders including ClearCardio(TM), company leadership and institutional investors, will fund commercialization of HeartBeam’s FDA-cleared 12-lead synthesized ECG system, further development of its extended-wear patch and heart attack detection technologies, expansion of AI capabilities and general corporate purposes

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.

Legal cannabis sales in Michigan rebounded sharply in March, even as retail prices continued to edge higher for a third month in a row, according to newly released figures from the state’s Cannabis Regulatory Agency.

Roth Capital Partners announced the appointment of Seth Appel as head of ATM and equity alternatives banking, bringing more than 30 years of capital markets experience to expand the firm’s equity capital markets capabilities and support growth companies in raising capital. In connection with the appointment, Appel will also serve as co-chief investment officer of the RoHo Capital Opportunities Fund, a joint venture with Horizon Technology Finance Corporation (NASDAQ: HRZN), focused on providing debt financing solutions to small- and micro-cap public companies.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.